drugset / Trial / NCT02585596
A Phase II Clinical Trial of YH23537 in Patients With Chronic Periodontal Disease.
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is designed to evaluate the efficacy and the safety of YH23537 in Korea patients with chronic periodontitis, in order to investigate the recommended therapeutic dose.
Timeline
- Start
- 2015-12-16
- Primary completion
- 2016-12-28
- Completion
- 2017-06-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | YH23537 | Unknown | 1000 mg | Oral |
| Subject | YH23537 | Unknown | 2000 mg | Oral |
| Subject | YH23537 | Unknown | 3000 mg | Oral |